Aradigm Corporation

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.
Hayward, US
16 (est)

Aradigm Corporation Locations

Hayward, US

Aradigm Corporation Metrics

Aradigm Corporation Summary

Founding Date


Market capitalization

$93.1 M

Closing share price


Aradigm Corporation Market Value History

Aradigm Corporation Company Life